title: The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent.
abstract: Streptococcus pneumoniae is the world's leading cause of pneumonia, bacteremia, meningitis and otitis media. A major pneumococcal virulence factor is the cholesterol-dependent cytolysin, which has the defining property of forming pores in cholesterol-containing membranes. In recent times a clinically significant and internationally successful serotype 1 ST306 clone has been found to express a non-cytolytic variant of Ply (Ply306). However, while the pneumococcus is a naturally transformable organism, strains of the ST306 clonal group have to date been virtually impossible to transform, severely restricting efforts to understand the role of non-cytolytic Ply in the success of this clone. In this study isogenic Ply mutants were constructed in the D39 background and for the first time in the ST306 background (A0229467) to enable direct comparisons between Ply variants for their impact on the immune response in a macrophage-like cell line. Strains that expressed cytolytic Ply were found to induce a significant increase in IL-1β release from macrophage-like cells compared to the non-cytolytic and Ply-deficient strains in a background-independent manner, confirming the requirement for pore formation in the Ply-dependent activation of the NLRP3 inflammasome. However, cytolytic activity in the D39 background was found to induce increased expression of the genes encoding GM-CSF (CSF2), p19 subunit of IL-23 (IL23A) and IFNβ (IFNB1) compared to non-cytolytic and Ply-deficient D39 mutants, but had no effect in the A0229467 background. The impact of Ply on the immune response to the pneumococcus is highly dependent on the strain background, thus emphasising the importance of the interaction between specific virulence factors and other components of the genetic background of this organism.
authors.affiliation: Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.
authors.forename: Richard M
authors.initials: RM
authors.lastname: Harvey
authors.affiliation: Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.
authors.forename: Catherine E
authors.initials: CE
authors.lastname: Hughes
authors.affiliation: Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.
authors.forename: Adrienne W
authors.initials: AW
authors.lastname: Paton
authors.affiliation: Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.
authors.forename: Claudia
authors.initials: C
authors.lastname: Trappetti
authors.affiliation: Department of Microbiology & Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
authors.forename: Rodney K
authors.initials: RK
authors.lastname: Tweten
authors.affiliation: Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.
authors.forename: James C
authors.initials: JC
authors.lastname: Paton
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology; D015153:Blotting, Western; D002478:Cells, Cultured; D017931:DNA Primers / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000378:metabolism; D058847:Inflammasomes / Q000378:metabolism; D053583:Interleukin-1beta / Q000378:metabolism; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D016133:Polymerase Chain Reaction; D017422:Sequence Analysis, DNA; D013045:Species Specificity; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000276:immunology*; D013301:Streptolysins / Q000235:genetics* / Q000276:immunology*
chemical_list: D001426:Bacterial Proteins; D017931:DNA Primers; D058847:Inflammasomes; D053583:Interleukin-1beta; D013301:Streptolysins; C032290:plY protein, Streptococcus pneumoniae; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
references.citation: Infect Immun. 2011 Oct;79(10):4122-30
references.pmid: 21788389
references.citation: PLoS Pathog. 2010 Nov 11;6(11):e1001191
references.pmid: 21085613
references.citation: Infect Immun. 2003 Jan;71(1):254-9
references.pmid: 12496173
references.citation: Infect Immun. 1995 May;63(5):1969-74
references.pmid: 7729909
references.citation: Appl Environ Microbiol. 2001 Nov;67(11):5190-6
references.pmid: 11679344
references.citation: J Infect Dis. 1995 Jul;172(1):119-23
references.pmid: 7797901
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1966-71
references.pmid: 12569171
references.citation: Infect Immun. 1999 Aug;67(8):3750-6
references.pmid: 10417133
references.citation: Infect Immun. 2000 May;68(5):3028-33
references.pmid: 10769009
references.citation: Clin Microbiol Infect. 2009 Sep;15(9):875-7
references.pmid: 19702591
references.citation: J Biol Chem. 1997 Jun 13;272(24):15366-72
references.pmid: 9182566
references.citation: Infect Immun. 1983 May;40(2):548-52
references.pmid: 6840851
references.citation: Biochim Biophys Acta. 1960 Apr 22;39:508-18
references.pmid: 14413322
references.citation: J Infect Dis. 2004 Mar 1;189(5):785-96
references.pmid: 14976594
references.citation: Immunology. 1991 Sep;74(1):60-7
references.pmid: 1937574
references.citation: Trends Immunol. 2004 Mar;25(3):143-9
references.pmid: 15036042
references.citation: Infect Immun. 2002 Oct;70(10):5454-61
references.pmid: 12228270
references.citation: J Infect Dis. 2001 Feb 15;183(4):604-11
references.pmid: 11170986
references.citation: J Infect Dis. 2004 May 15;189(10):1905-13
references.pmid: 15122528
references.citation: Methods Enzymol. 1993;217:270-9
references.pmid: 8474334
references.citation: Infect Immun. 1994 Dec;62(12):5683-8
references.pmid: 7960154
references.citation: Clin Infect Dis. 2006 Feb 15;42(4):451-9
references.pmid: 16421787
references.citation: J Immunol. 2012 Jan 15;188(2):811-7
references.pmid: 22156592
references.citation: Infect Immun. 2008 Jun;76(6):2678-84
references.pmid: 18391006
references.citation: Dev Biol Stand. 1995;85:293-300
references.pmid: 8586192
references.citation: Rev Panam Salud Publica. 2013 Jun;33(6):422-6
references.pmid: 23939367
references.citation: Clin Infect Dis. 2006 Sep 15;43(6):693-700
references.pmid: 16912941
references.citation: Infect Immun. 1984 Mar;43(3):1085-7
references.pmid: 6698602
references.citation: PLoS One. 2011 May 05;6(5):e19650
references.pmid: 21573186
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4341-6
references.pmid: 20145114
references.citation: Int J Antimicrob Agents. 2010 Feb;35(2):107-13
references.pmid: 20005681
references.citation: Infect Immun. 1994 Apr;62(4):1501-3
references.pmid: 8132361
references.citation: J Biol Chem. 1998 Feb 6;273(6):3551-61
references.pmid: 9452482
references.citation: J Clin Microbiol. 2010 Aug;48(8):2968-71
references.pmid: 20534799
references.citation: Nature. 2006 May 11;441(7090):231-4
references.pmid: 16648837
references.citation: J Clin Microbiol. 2006 Jan;44(1):151-9
references.pmid: 16390963
references.citation: J Infect Dis. 2005 Jul 15;192(2):192-9
references.pmid: 15962213
references.citation: mBio. 2013 Sep 10;4(5):e00655-13
references.pmid: 24023386
references.citation: PLoS One. 2010 Jan 13;5(1):e8668
references.pmid: 20084270
references.citation: Infect Immun. 1994 Jun;62(6):2582-9
references.pmid: 8188381
references.citation: FEMS Immunol Med Microbiol. 2009 Apr;55(3):346-51
references.pmid: 19291171
references.citation: J Infect Dis. 2003 May 1;187(9):1424-32
references.pmid: 12717624
references.citation: BMC Microbiol. 2008 Nov 17;8:198
references.pmid: 19014613
references.citation: J Exp Med. 1944 Feb 1;79(2):137-58
references.pmid: 19871359
references.citation: Infect Immun. 2006 Jan;74(1):586-93
references.pmid: 16369015
references.citation: Infect Immun. 2000 Feb;68(2):492-501
references.pmid: 10639409
references.citation: BMC Infect Dis. 2013 Sep 03;13:409
references.pmid: 24138669
references.citation: Mol Microbiol. 2000 Mar;35(6):1431-42
references.pmid: 10760144
references.citation: Infect Immun. 1989 Jul;57(7):2037-42
references.pmid: 2731982
references.citation: Infect Immun. 1991 Jul;59(7):2297-304
references.pmid: 2050399
references.citation: Nat Rev Immunol. 2008 Jul;8(7):533-44
references.pmid: 18551128
references.citation: Curr Opin Immunol. 2007 Jun;19(3):281-6
references.pmid: 17433650
references.citation: J Immunol. 2011 Jul 1;187(1):434-40
references.pmid: 21646297
references.citation: J Clin Invest. 2009 Jul;119(7):1899-909
references.pmid: 19509469